PTK2 and pulmonary fibrosis: In vivo and in vitro experiments have shown that the invasion ability of invasive lung fibroblasts and the severity of pulmonary fibrosis in mice could be attenuated by knocking out PD-L1 in fibroblasts and targeting PD-L1 using anti-PD-L1 mAb and FAK inhibitor.